PD-L1 positive tumors (tumor proportion score > 1%) displayed higher T- and B-cell levels than did PD-L1 negative tumors, with CD20+ B-lymphocytes demonstrating statistical significance (Fig. 2E, F, G). The gene discussed is CD274; the disease is neoplasm.